The subcellular localization of 13 recently identified N-myristoylated proteins and the effects of overexpression of these proteins on cellular morphology were examined with the aim of understanding the physiological roles of the protein N-myristoylation that occurs on these proteins. Immunofluorescence staining of HEK293T cells transfected with cDNAs coding for the proteins revealed that most of them were associated with the plasma membrane or the membranes of intracellular compartments, and did not affect cellular morphology. However, two proteins, formin-like2 (FMNL2) and formin-like3 (FMNL3), both of them are members of the formin family of proteins, were associated mainly with the plasma membrane and induced significant cellular morphological changes. Inhibition of protein N-myristoylation by replacement of Gly2 with Ala or by the use of N-myristoylation inhibitor significantly inhibited membrane localization and the induction of cellular morphological changes, indicating that protein N-myristoylation plays critical roles in the cellular morphological changes induced by FMNL2 and FMNL3.
The subcellular localization of 13 recently identified N-myristoylated proteins and the effects of overexpression of these proteins on cellular morphology were examined with the aim of understanding the physiological roles of the protein N-myristoylation that occurs on these proteins. Immunofluorescence staining of HEK293T cells transfected with cDNAs coding for the proteins revealed that most of them were associated with the plasma membrane or the membranes of intracellular compartments, and did not affect cellular morphology. However, two proteins, formin-like2 (FMNL2) and formin-like3 (FMNL3), both of them are members of the formin family of proteins, were associated mainly with the plasma membrane and induced significant cellular morphological changes. Inhibition of protein N-myristoylation by replacement of Gly2 with Ala or by the use of N-myristoylation inhibitor significantly inhibited membrane localization and the induction of cellular morphological changes, indicating that protein N-myristoylation plays critical roles in the cellular morphological changes induced by FMNL2 and FMNL3.
Key words: protein N-myristoylation; formin-like2 (FMNL2); formin-like3 (FMNL3); formin family protein; cellular morphological change Protein N-myristoylation is a well-recognized form of lipid modification that occurs on eukaryotic and viral proteins. [1] [2] [3] [4] [5] In general, protein N-myristoylation is an irreversible co-translational protein modification. In this process, myristic acid, a 14-carbon saturated fatty acid, is attached to the N-terminal Gly residue of the protein after removal of the initiating Met. N-Myristoylation is catalyzed by N-myristoyltransferase (NMT), a member of the GCN5-related N-acetyltransferase (GNAT) superfamily of proteins. 6) Many N-myristoylated proteins play critical roles in regulating cellular structure and function. These include proteins involved in a wide variety of cellular signal transduction pathways, including protein kinases, phosphatases, guanine nucleotidebinding proteins, and Ca 2þ -binding proteins. In many cases, the functions of these N-myristoylated proteins are regulated by reversible protein-membrane interactions mediated by protein N-myristoylation, as in the case of G protein subunits and src family tyrosine kinases. 1, 4, 7) In some cases, such as that of CAP-23/ NAP-22, specific protein-protein interactions mediated by protein N-myristoylation play critical roles in the expression of protein function. 8) Identification of N-myristoylated proteins expressed in cells or tissues is done by mass spectrometric analysis or by metabolic labeling experiments. 9, 10) By these strategies, only the major N-myristoylated proteins included in the cells or tissues can be detected, because only limited amounts of proteins and limited sets of genes are expressed in particular cells and tissues. Hence these strategies are not useful for comprehensive analysis of the N-myristoylated proteins expressed in cells and tissues.
In a previous study, to establish a strategy for comprehensive identification of human N-myristoylated proteins, the susceptibility of human cDNA clones in human cDNA resources to protein N-myristoylation was evaluated by metabolic labeling and mass spectrometric analysis of the proteins expressed using an insect cellfree protein synthesis system. 11) For this analysis, 141 cDNA clones with an N-terminal Met-Gly motif were selected as candidates from approximately 2,000 Kazusa ORFeome Project (KOP) human cDNA clones. The susceptibility of these cDNA clones to protein Nmyristoylation was evaluated using fusion proteins, in which the N-terminal 10 amino acid residues were fused to an epitope-tagged model protein. Then protein Nmyristoylation on the gene product of the full-length cDNA was evaluated by metabolic labeling experiments in an insect cell-free protein synthesis system and in transfected COS-1 cells.
12) The protein products of 27 out of the approximately 2,000 cDNA clones were found to be N-myristoylated. Database searches with these 27 cDNA clones revealed that 9 out of 27 are known N-myristoylated proteins that play critical roles in cellular signal transduction pathways, including the G protein subunit (Gi1), the ADP-ribosylation factor (Arf1), phospho-diesterase (PDE2A), and non-receptor tyrosine kinase (Abl1). Ten proteins out of the 18 novel Nmyristoylated proteins were functionally unknown proteins. The remainder of the novel N-myristoylated proteins were key players in various cellular signal transduction pathways, including phosphatase, ubiquitin E3-ligase, cytoskeletal regulatory protein, apoptosisrelated protein, and amino acid transporter. Thus it is probable that protein N-myristoylation plays critical roles in the functions of these proteins. In fact, it was reported recently that protein N-myristoylation of RNF11, one of the 18 novel N-myristoylated proteins, plays critical roles in the intracellular localization and function of this protein. 13) In this study, the subcellular localization and the cellular morphological changes induced by these novel N-myristoylated proteins were examined in order to understand the physiological roles of the protein Nmyristoylation that occurs on these proteins. It was found that two proteins, formin-like 2 (FMNL2) and formin-like 3 (FMNL3), both of them are members of the formin family, were associated mainly with the plasma membrane, and induced significant cellular morphological changes. Inhibition of protein N-myristoylation by the replacement of the Gly2 of these proteins with Ala or by the use of 2-hydroxymyristic acid (2-HM), a potent inhibitor of protein N-myristoylation, significantly inhibited membrane localization and the induction of cellular morphological changes, indicating that protein N-myristoylation plays critical roles in these reactions. Thus it was found that cellular expression of two formin family proteins, FMNL2 and FMNL3, induces significant cellular morphological changes that are dependent on protein N-myristoylation.
Materials and Methods
Materials. Restriction endonucleases, DNA-modifying enzymes, RNase inhibitor, and Taq DNA polymerase were purchased from Takara Shuzo (Kyoto, Japan). RNase was from Boehringer-Mannheim (Mannheim, Germany Plasmid construction. Plasmid pcDNA3-FL, used as the mammalian expression vector, was constructed as described previously. 11) To construct pcDNA3 plasmids containing full-length KOP cDNA clones, pcDNA3-FL was treated with SgfI and EcoRV, and KOP cDNA clones digested with SgfI and PmeI were subcloned into the vector. Plasmid pcDNA3-FXC00892-G2A-Flag was constructed by polymerase chain reaction (PCR) using two oligonucleotides, SgfI-FXC00892-G2A N, 5
0 -ATATGCGATCGCCATGGCCAGCACCCTGGGCTGC-3 0 and pF1K T7-sequence C, 5 0 -GTTTAGAGGCCCCAAGGGGGT-3 0 , with pF1K-892 as template. After digestion with SgfI and PmeI, the amplified fragments were subcloned into pcDNA3-FL at the SgfI and EcoRV sites. Plasmid pcDNA3-FXC01433-G2A-FLAG was constructed by PCR using two oligonucleotides, SgfI-FXC01433-G2A N, 5 0 -ATATGCGATCGCCATGGCCTCCCAGGTCTCGGTG-3 0 and pF1K T7-sequence C, 5 0 -GTTTAGAGGCCCCAAGGGGGT-3 0 , with pF1K-4745 as template. After digestion with Sgfl and PmeI, the amplified fragments were subcloned into pcDNA3-FL at the Sgfl and EcoRV sites. Plasmid pcDNA3-FXC1184-G2A-FLAG was constructed by PCR using two oligonucleotides, SgfI-FM2-G2A N, 5
0 -ATATGCGA-TCGCGATGGCAAACGCAGGGAGCATG-3 0 and FM2-Ástop-PmeI C, 5 0 -GCGCGTTTAAACCATTGTTATTTCGGC-3 0 , as primers, pcDNA3-FXC1184 11) as template. After digestion with SgfI and PmeI, the amplified fragments were subcloned into the SgfI-EcoRV sites of pcDNA3-FL. Plasmid pcDNA3-FXC1701-G2A-FLAG was constructed by the same strategy as for pcDNA3-FXC1184-G2A-FLAG, using two oligonucleotides, SgfI-FXC1701-G2A N, 5
0 -GCATGCGATCGCCAT-GGGCAACCTGGAGAGCGCC-3 0 and FXC1701-PmeI C, 5 0 -ATAT-GTTTAAACCGTGGGGGCCTGGAGT-3 0 , as primers, with pcDNA3-FXC1701-FLAG 11) as template. Plasmid pcDNA3-EGFP, containing the cDNA coding for EGFP, was constructed by PCR using two oligonucleotides, EcoRV-EGFP N, 5
0 -GCGCGATATCATGGTGAG-CAAGGGC-3 0 and EGFP-NotI C, 5 0 -ATATGCGGCCGCTTACTTG-TACAGCTC-3 0 , as primers, pEGFP-N1 (Invitrogen, Carlsbad, CA) as template. After digestion with EcoRV and NotI, the amplified fragment was subcloned into pcDNA3 at the EcoRV and NotI sites. Plasmid pcDNA3-FXC1701-EGFP was constructed by PCR using two oligonucleotides, EcoRI-FM3 N, 5
0 -GCGCGAATTCATGGGCAACCTG-GAG-3 0 and FM3-EcoRV-Ástop C, 5 0 -ATATGATATCGTGGGGG-CCTGGAGT-3 0 , as primers, with pF1KA2014 as template. After digestion with EcoRI and EcoRV, the amplified fragments were subcloned into the EcoRI-EcoRV sites of pcDNA3-EGFP. Plasmid pcDNA3-FXC1701-G2A-EGFP was constructed by the same strategy as for pcDNA3-FXC1701-EGFP, using two oligonucleotides, EcoRI-FM3-G2A N, 5 0 -GCGCGAATTCATGGCCAACCTGGAG-3 0 and FM3-EcoRV-Ástop C, 5 0 -ATATGATATCGTGGGGGCCTGGAGT-3 0 , with pF1KA2014 as template. The DNA sequences of these recombinant cDNAs were confirmed by the dideoxy-nucleotide chain termination method.
Transfection of HEK293T cells. HEK293T cells were maintained in Dulbecco's Modified Eagle's Medium (DMEM; Gibco BRL, Palo Alto, CA) supplemented with 10% fetal calf serum (FCS; Gibco BRL). Cells (2 Â 10 5 ) were plated onto 35-mm diameter dishes 1 d before transfection. pcDNA3 constructs (2 mg) containing cDNAs coding for FLAG-tagged proteins were used to transfect the HEK293T cells in each plate along with 4 mL of Lipofectamine (2 mg/mL, Gibco BRL) in 1 mL of serum-free medium. After incubation for 5 h at 37 C, the cells were re-fed with serum-containing medium and incubated again at 37 C for appropriate periods.
Detection of protein N-myristoylation. HEK293T cells (2 Â 10 5 ) were transfected with pcDNA3 constructs (2 mg) containing cDNAs, as described above, and incubated at 37 C for 24 h. Then they were washed twice with 1 mL of serum-free DMEM and incubated for 6 h at 37 C in 1 mL of DMEM (+2% FCS) containing [ 3 H]myristic acid (100 mCi/mL). Subsequently, they were washed 3 times with Dulbecco's phosphate-buffered saline (DPBS) and collected with a cell scraper, and lysed with 200 mL of RIPA buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 1% Nonidet P-40, 0.5% sodium deoxycholate, 0.1% sodium dodecyl sulfate, and proteinase inhibitors) on ice for 20 min. The samples were then analyzed by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and fluorography. When the effect of 2-hydroxymyristic acid (2-HM) on protein Nmyristoylation was studied, after transfection, the cells were incubated for 12 h in 1 mL of DMEM (+2% FCS) containing various concentrations of 2-HM. They were then washed twice with 1 mL of serumfree DMEM and incubated for 6 h at 37 C in 1 mL of DMEM (+2% FCS) containing [
3 H]myristic acid (100 mCi/mL) and the each concentration of 2-HM. Subsequently, they were washed and lysed as described above, and the labeled proteins were analyzed by SDS-PAGE and fluorography.
SDS-PAGE and fluorography. Samples were denatured by boiling for 3 min in SDS-sample buffer, followed by analysis by SDS-PAGE on a 12.5% gel. Then the gel was fixed and soaked in ENLIGHTNING (PerkinElmer; Waltham, MA) for 20 min. It was dried under vacuum and exposed to X-ray film (Eastman Kodak, Rochester, NY) for an appropriate period. Quantitative analysis of the labeled proteins was carried out by scanning the fluorogram using an imaging densitometer (Bio-Rad GS-700).
Western blotting. The cell lysates of each group of transfected cells were prepared 24 h after transfection and resolved by 12.5% SDS-PAGE, and then transferred to an Immobilon-P transfer membrane (Millipore, Billerica, MA). After blocking with nonfat milk, the membrane was probed with a specific anti-FLAG or anti-EGFP antibody, as described previously. 14) Immunoreactive proteins were specifically detected by incubation with horseradish peroxidaseconjugated protein G (Bio-Rad, Hercules, CA). The membrane was developed using enhanced chemiluminescence Western blotting reagent (Amersham Biosciences, Buckinghamshire, UK) and exposed to X-ray film (Eastman Kodak). Quantitative analysis of immunoreactive proteins was carried out by scanning the X-ray film using an imaging densitometer (Bio-Rad GS-700).
Immunofluorescence analysis, fluorescence microscopy, and determination of cellular morphological changes. Immunofluorescence analysis of transfected cells was performed 24 h after transfection. 15) For immunocytochemistry, the cells were washed with DPBS, fixed in 4% paraformaldehyde in DPBS for 15 min, and permeabilized with 0.1% Triton X-100 in DPBS for 10 min at room temperature, followed by washing with 0.1% gelatin in DPBS. The permeabilized cells were incubated with anti-FLAG antibody (1:1,000) in DPBS for 1 h at room temperature. After washing with 0.1% gelatin in DPBS, the cells were incubated with a fluorescein isothiocyanate-conjugated anti-mouse IgG antibody or an Alexa Fluor 594 rabbit anti-mouse IgG antibody for 1 h at room temperature. After washing with 0.1% gelatin in DPBS, the cells were observed using a Leica AF7000 fluorescence microscope (Leica, Solmser, Germany). When the effect of 2-HM on the cellular morphological changes was studied, after transfection, the cells were incubated for 24 h in 1 mL of DMEM (+2% FCS) containing 250 mM 2-HM. Then immunofluorescence analysis was done as described above. Quantitative analysis of the cellular morphological changes was done by fluorescence microscopic analysis. Cells having unusual membrane protrusions were counted by fluorescence microscopic observation of 100 immunofluorescence-positive (transfected) cells. The extent of cellular morphological changes was expressed as the percentage of the number of cells having membrane protrusions against the total number of transfected cells.
Results

FMNL2 and FMNL3 induced significant cellular morphological changes when expressed in mammalian cells
The novel N-myristoylated proteins analyzed in this study are listed in Supplemental Table 1 (see Biosci. Biotechnol. Biochem. Web site). In order to determine the physiological roles of the protein N-myristoylation that occurs on these proteins, their subcellular localization was analyzed by immunofluorescence staining. HEK293T cells were transfected with cDNAs tagged with the FLAG-tag at the 3 0 end of the coding sequence. After 24 h, the cells were fixed and stained with specific primary and secondary antibodies, as described in ''Materials and Methods.'' The results of immunofluorescence staining revealed that 13 cDNAs were expressed successfully in the cells, but obvious protein expression was not observed for five cDNA clones. As shown in Fig. 1A , a, b, c and Supplemental Fig. 1 (see Biosci. Biotechnol. Biochem. Web site), most of the expressed proteins were localized either to the plasma membrane (FXC128, 876, 892, and 905) or to intracellular compartments (FXC557, 721, 896, 950, 1433, 1513, and 1828) and did not affect cellular morphology. In contrast, two proteins, FMNL2 (FXC1184) and FMNL3 (FXC1701), both of which are members of the formin family, were associated mainly with the plasma membrane, and induced significant cellular morphological changes such as the formation of filopodia and membrane protrusions, as shown in Fig. 1A, d and e.
To determine whether the morphological changes induced by FMNL2 and FMNL3 are specific phenomena or nonspecific events caused by overexpression of Nmyristoylated proteins, the levels of protein expression of FMNL2 and FMNL3 were compared with that of three other N-myristoylated proteins, FXC128, FXC557, FXC896. HEK293T cells were transfected with each of the various plasmids containing cDNAs with sequences encoding the FLAG tag at the 3 0 end. After 24 h, total cell lysates were obtained, and were analyzed by Western blotting using an anti-Flag antibody. As shown in Fig. 1B , the amount of expressed proteins of FAM131B (FXC128) and MGRN1 (FXC557), which do not induce cellular morphological changes, was much higher than that of FMNL2 and FMNL3. It was also found that the level of protein expression of FMNL2 was much lower than that of FMNL3. When the same set of five cDNA clones was transfected to HEK293T cells, the cellular morphological changes were determined by immunofluorescence staining, and the extent of cellular morphological changes was compared, significant differences were observed among the five cDNA clones (Fig. 1C) . In the case of FMNL2 and FMNL3, morphological changes were observed in about 70% of the transfected (immunofluorescence-positive) cells. In contrast, as for the three N-myristoylated proteins that localized to the plasma membrane or to intracellular compartments, cellular morphological changes were observed in less than 10% of the transfected cells.
Protein N-myristoylation was essential for the cellular morphological changes induced by FMNL2 and FMNL3
Next we evaluated the role of protein N-myristoylation on the cellular morphological changes induced by FMNL2 and FMNL3. To confirm that FMNL2 and FMNL3 were N-myristoylated, metabolic labeling of HEK293T cells transfected with cDNAs coding for FLAG-tagged FMNL2 and FMNL3 was done. As shown in Fig. 2A (upper panel, lanes 1 and 3) , transfection of HEK293T cells with cDNAs coding for FLAG-tagged FMNL2 and FMNL3 gave rise to protein bands with the expected molecular masses (124-kDa FMNL2 plus 1-kDa FLAG-tag, and 117-kDa FMNL3 plus 1-kDa FLAG-tag respectively). The 125-kDa and 118-kDa protein bands were efficiently N-myristoylated, as determined by [ 3 H]myristic acid labeling ( Fig. 2A,  lower panel, lanes 1 and 3) . When Gly2 of FMNL2-FLAG and FMNL3-FLAG was replaced with Ala (FMNL2-G2A-FLAG and FMNL3-G2A-FLAG respectively), no incorporation of [ 3 H]myristic acid into these mutants was observed despite the effective expression of these proteins, as shown in Fig. 2A (upper panel lanes 2  and 4, and lower panel lanes 2 and 4) . Immunofluorescence staining of FMNL2-FLAG and FMNL3-FLAG revealed that these proteins localized largely to the plasma membrane and induced remarkable cellular morphological changes, whereas staining of FMNL2-G2A-FLAG and FMNL3-G2A-FLAG showed diffuse cytosolic distribution without induction of cellular morphological changes (Fig. 2B) . Quantitative analysis of the cellular morphological changes induced by these two sets of proteins revealed that inhibition of protein N-myristoylation by replacement of Gly2 with Ala significantly reduced the ability of FMNL2 and FMNL3 to induce cellular morphological changes (Fig. 2C) . These results clearly indicate that protein N-myristoylation is essential for membrane localization and for the cellular morphological changes induced by FMNL2 and FMNL3.
In order to confirm further the role of protein Nmyristoylation in membrane localization and the induction of cellular morphological changes induced by FMNL2 and FMNL3, the effect of 2-hydroxymyristic acid (2-HM), a potent inhibitor of protein N-myristoylation, on these reactions was examined. As shown in Fig. 3A , protein expression and protein N-myristoylation of FMNL3-FLAG expressed in HEK293T cells was dose-dependently inhibited as the concentration of 2-HM increased. At a concentration of 250 mM, protein N-myristoylation was strongly inhibited without any obvious decrease in the amount of expressed protein.
The results of immunofluorescence staining of HEK293T cells transfected with cDNA coding for FMNL2 or FMNL3 in the presence 250 mM 2-HM revealed that the membrane localization and the morphological changes induced by these proteins were significantly inhibited by 2-HM, and difuse cytosolic distribution was observed for these two proteins, as shown in Fig. 3B .
Effect of cellular expression of FMNL2 and FMNL3 on the status of cellular actin filaments
Because formin family proteins have been found to promote the formation of actin networks and to be involved in the regulation of cellular actin-dependent processes, the effects of the expression of FMNL2 and FMNL3 on the status of cellular actin filaments were evaluated. HEK293T cells trasfected with cDNA coding for FMNL2 or FMNL3 were stained with fluorescencelabeled phalloidin, and the status of the actin filaments was observed by fluorescence microscopy. As shown in Fig. 4A and B, the images of immunofluorescence staining of the wild-type FMNL2 and FMNL3 largely overlapped with the images of phalloidin staining. In contrast, those of the G2A mutants of FMNL2 and FMNL3 did not overlapped with the images of phalloidin staining.
Time-dependence of cellular morphological changes in HEK293T cells induced by FMNL3
To examine the time-dependence of cellular morphological changes induced by FMNL3, time-lapse analysis was performed using FMNL3 C-terminally tagged with EGFP. As shown in Fig. 5A , EGFP expressed in the HEK293T cells showed difuse cytosolic and nuclear localization as detected by EGFP fluorescence. In the case of FMNL3-EGFP, membrane localization and the induction of cellular morphological changes was observed, as is the case with FMNL3-FLAG. As for FMNL3-G2A-EGFP, diffuse cytosolic distribution was observed without induction of cellular morphological changes. In this case, nuclear localization was not observed, probably due to the high molecular weight of FMNL3-G2A-EGFP. Quantitative analysis of the cellular morphological changes induced by these three proteins confirmed that inhibition of protein N-myristoylation by replacement of Gly2 with Ala dramatically reduced the ability of FMNL3-EGFP to induce cellular morphological changes (Fig. 5B) .
When EGFP was fused to the C-terminus of FMNL2, the ability of FMNL2 to induce cellular morphological changes decreased significantly (data not shown). Hence time-lapse analysis was performed using FMNL3-EGFP. As shown in Fig. 5C , membrane localization and the induction of cellular morphological changes occurred concurrently with cellular expression of FMNL3-EGFP. In contrast, the cellular expression of FMNL3-G2A-EGFP was not accompanied by the induction of cellular morphological changes.
Discussion
Protein N-myristoylation is a typical lipid modification that occurs on eukaryotic and viral proteins. Many N-myristoylated proteins bind to membranes and are found associated with the plasma membrane or other intracellular membranes in eukaryotic cells. Inhibition of protein N-myristoylation, by the mutation of Gly2 to Ala, generally results in a reduction or the loss of membrane localization. 1, 2, 4) In fact, 11 out of 13 novel N-myristoylated proteins tested in this study were found to localize either to the plasma membrane or to intracellular compartments when expressed in HEK293T cells. In the case of two proteins, FMNL2 and FMNL3, members of the formin family, they were associated mainly with the plasma membrane and induced significant cellular morphological changes, such as the formation of membrane protrusions. The levels of protein expression of these two proteins were lower than those of other N-myristoylated proteins that do not induce cellular morphological changes, indicating that the induction of cellular morphological changes induced by FMNL2 and FMNL3 is not nonspecific events caused by the overexpression of N-myristoylated proteins, but is a specific phenomenon induced by these proteins.
Formin family proteins have been found to promote the formation of actin networks and to be involved in the regulation of cellular actin-dependent processes including cell division, migration, adhesion, intracellular trafficking, and morphogenesis. [16] [17] [18] [19] [20] Formins are defined by a highly conserved C-terminal formin homology (FH) 2 domain that mediates actin polymerization. 21, 22) The FH2 domain is preceded by the FH1 domain, which binds to profilin. HEK293T cells transfected with cDNAs coding for wild-type and G2A mutants of FMNL2 or FMNL3 were stained with fluorescence-labeled phalloidin, and the status of the actin filaments was observed by fluorescence microscopy. FLAG, immunofluorescence staining using anti-FLAG antibody; Phalloidin, phalloidin staining using TRITC-conjugated phalloidin. A, Results for FMNL2-FLAG and FMNL2-G2A-FLAG. B, Results for FMNL3-FLAG and FMNL3-G2A-FLAG.
A subset of formins is classified as Diaphanousrelated formins (DRFs) based on the presence of a Cterminal diaphanous autoregulatory domain (DAD) first identified in mDia1, 21) the mammalian homolog of the Drosophila Diaphanous protein. In DRFs, the FH1 and FH2 domains are flanked by several regulatory domains at the N-terminus and by a DAD at the C-terminus. 24) The N-terminal regulatory region includes a GTPase binding domain (GBD), followed by a Diaphanousinhibitory domain (DID) and a dimerization domain (DD). 23, [25] [26] [27] The binding of DAD to DID is responsible for auto-inhibition of DRFs.
Formin-like proteins FMNL1, FMNL2, and FMNL3 constitute a family of Diaphanous-related formins in mammals. FMNL1 is the human leukocyte formin, it is highly expressed in the thymus, spleen, and peripheral blood leukocytes. FMNL2 is expressed ubiquitously in human tissues, 28) but the tissue distribution of FMNL3 is not well characterized. FMNL1 is autoinhibited by DID-DAD interaction and becomes activated by GTPase Cdc42. 29) FMNL2 is also autoinhibited and is activated by GTPase RhoC. 30, 31) In contrast, FMNL3 has been found to be constitutively active in cells even though its DID and DAD bind to one another in vitro. 29) However, a recent study found that FMNL3, but not FMNL2, is a RhoC-specific target, and is involved in cancer cell invasion. 32 ) Thus the precise mechanisms of the activation of FMNL2 and FMNL3 remain to be elucidated.
Depletion of FMNL1 in cytotoxic lymphocytes led to abrogation of cell-mediated killing, indicating that a crucial role of this formin in the dramatic morphological changes of activated T cells. It has been reported that a high expression level of FMNL1 is to be observed in several lymphoid cancer cell lines. 33) FMNL2 expression was found to be elevated in colorectal metastatic cancer cell lines as compared with normal colorectal cancer cell lines. 34, 35) Not much is known about the function of FMNL3, but one study found that it was downregulated in cells with reduced tumorigenic capacity. 36) In addition, it was recently found that FMNL3 is a RhoC-specific target, and is involved in cancer cell invasion. 32) As for the protein N-myristoylation occurs in formin family proteins, it was found recently that FMNL1, a newly identified splice variant of FMNL1, is Nmyristoylated, and that N-myristoylation is required for plasma membrane localization and for the membrane bleb formation induced by FMNL1. 37) However, two previously identified isoforms of FMNL1, FMNL1 and FMNL1, neither localized to the plasma membrane nor induced cellular morphological changes when expressed in mammalian cells. In FMNL1 and FMNL1, however, similar membrane localization and bleb formation was observed for a mutant lacking the DAD domain (FMNL1ÁDAD), indicating that deregulation of autoinhibition is effective in FMNL1. In the present study, it was found that FMNL2 and FMNL3 are N-myristoylated, and that N-myristoylation is required for plasma membrane localization and for the cellular morphological changes induced by FMNL2 and FMNL3. A database search of UniProt Knowledgebase (UniProtKB) revealed that FMNL2 and FMNL3 have two and three isoforms respectively. In these isoforms, the N-myristoylation motif at the Nterminus was highly conserved and differences in amino acid sequence were observed mainly in the Cterminal approximately 30 amino acids. In this study, isoform 2 of FMNL2 and isoform 3 of FMNL3 were used. In order to determine whether differences in the function of FMNL2 and FMNL3 were observed among isoforms, we are currently constructing cDNAs of these isoforms.
Concerning the mechanisms of membrane binding mediated by protein N-myristoylation, it is generally admitted that N-myristoylation facilitates the anchoring of proteins to lipid membranes by hydrophobic interaction of the myristate moiety with the membrane bilayer. While protein N-myristoylation is clearly required for membrane binding, the binding energy provided by myristate is relatively weak, and is not sufficient fully to anchor a protein to a cellular membrane. 38) Therefore, a second signal within the Nmyristoylated protein is required for efficient membrane binding. The second signal for the membrane binding of N-myristoylated proteins has been defined as either a cluster of positively charged amino acids or protein palmitoylation. Alternatively, additional protein-protein interactions can occur at the plasma membrane. These serve to enhance the binding of N-myristoylated proteins to the cellular membrane. 4, 39) In the case of FMNL2 and FMNL3, no cluster of positively charged amino acids and no cystein residue that might be palmitoylated were observed within 30 residues of the N-terminus, suggesting that the membrane binding of FMNL2 and FMNL3 was not mediated by either of these mechanisms. Because FMNL2 and FMNL3 have GTPase binding domains (GBDs) close to the N-myristoylated Nterminus, interaction of the GBD with membrane-bound Rho GTPase might be the second signal for the membrane binding of FMNL2 and FMNL3. Thus a combination of the N-terminal myristoyl group and GTPase binding might facilitate the stable membrane binding of FMNL2 and FMNL3. Further studies are required to clarify fully the molecular mechanisms of membrane binding and of the induction of cellular morphological changes.
In the present study, it was found that protein Nmyristoylation is required for membrane binding and the cellular morphological changes induced by FMNL2 and FMNL3. When the N-terminal sequences of all the formin family proteins were surveyed, it was found that FMN2 has a possible N-myristoylation motif at the Nterminus. 40) Hence it is possible that protein N-myristoylation plays a role in the function of FMN2. In addition, it was reported recently that IFN2, a formin family protein, is modified by a C-terminal farnesyl group, and that this modification is required for the specific association of IFN2 with the endoplasmic reticulum. 41) Thus lipid modification occurring at either the N-terminus or C-terminus appears to be a critical structural determinant for some formin family proteins.
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